Axogen Inc.

AXGN NASDAQ
21.33
+0.32
+1.52%
After Hours: 21.33 0 0.00% 16:35 05/24 EDT
Open
21.12
Prev Close
21.01
High
21.84
Low
20.90
Volume
223.11K
Avg Vol (3M)
513.65K
52 Week High
56.85
52 Week Low
14.13
% Turnover
0.57%
Market Cap
835.07M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
MORE >

Recently

Name
Price
%Change